Founder And Ceo
CurrentNew biological therapeutic discovery in retinal diseases (GA, AMD, DME, DR, Neuroprotection)
Please complete the CAPTCHA to continue
@santen.com
✓
3 phones found area 415 and 562
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Jack Chen is listed as Founder and CEO at Shenzhen Oculgen Biomedical Technology Co., Ltd., based in Berkeley, California, United States. AeroLeads shows a work email signal at santen.com, phone signal with area code 415, 562, and a matched LinkedIn profile for Jack Chen.
Jack Chen previously worked as Director, New Biologics Research. Therapeutic Modality and Innovation at Santen and Sr. Scientist at Allergan. Jack Chen holds Postdoc from University Of California, San Francisco.
This section adds company-level context without repeating Jack Chen's masked contact details.
AeroLeads found 2 current-domain work email signals for Jack Chen. Compare company email patterns before reaching out.
Jack Chen is a Founder and CEO at Shenzhen Oculgen Biomedical Technology Co., Ltd.. He possess expertise in pcr, molecular biology, western blotting, cell culture, biochemsitry and 20 more skills. He is proficient in English.
Listed skills include Pcr, Molecular Biology, Western Blotting, Cell Culture, and 21 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
New biological therapeutic discovery in retinal diseases (GA, AMD, DME, DR, Neuroprotection)
Dublin, Coolock, Ie
• Rational design of novel antibody, GPCR or fusion protein/antibody engineering, purification and characterization (HPLC, FPLC, MS, CE, etc) from mammalian (HEK, CHO, and HUVEc), E. coli and/or other expression systems. • Manage several internal and external collaborations. • Engineered and produced carious recombinant antibody/proteins from competitors • High through put screening binding (Octet) and cellular (ELISA) assays development. • Produced multiple species target material for DARPin selection and screening.• Investigated target role in cellular receptor complex. Isolated intact, native protein complex from primary cells. This complex was used for binding analysis for leading candidates selection to important insight that triggered a shift in strategy. • Investigated selected protein role in biological pathway, produced target protein and benchmark antibody. These materials were used directly to initiate DARPin selection and in vitro/in vivo experiments
Quick answers generated from the profile data available on this page.
Jack Chen works for Shenzhen Oculgen Biomedical Technology Co., Ltd..
Jack Chen is listed as Founder and CEO at Shenzhen Oculgen Biomedical Technology Co., Ltd..
AeroLeads has found 2 work email signals at @santen.com for Jack Chen at Shenzhen Oculgen Biomedical Technology Co., Ltd..
AeroLeads has found 3 phone signal(s) with area code 415, 562 for Jack Chen at Shenzhen Oculgen Biomedical Technology Co., Ltd..
Jack Chen is based in Berkeley, California, United States while working with Shenzhen Oculgen Biomedical Technology Co., Ltd..
Jack Chen has worked for Shenzhen Oculgen Biomedical Technology Co., Ltd., Santen, Allergan, Uci Mb&B And Cancer Research Center, and Ucsf.
You can use AeroLeads to view verified contact signals for Jack Chen at Shenzhen Oculgen Biomedical Technology Co., Ltd., including work email, phone, and LinkedIn data when available.
Jack Chen holds Postdoc from University Of California, San Francisco.
Jack Chen is listed with skills including Pcr, Molecular Biology, Western Blotting, Cell Culture, Biochemsitry, Mass Spectrometry, Maldi Ms, and Gc Ms.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts